Clinical Trial Update: Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

The document summarizes Phase 2 trial results assessing the safety and efficacy of S-8184 as second-line treatment for relapsed stage IIIB/IV non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• S-8184

Snippet

Sponsor: Achieve Life Sciences | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED